M. Corominas et al., DISTINCT MODULATION BY INTERFERON-GAMMA (IFN-GAMMA) OF CD23 EXPRESSION ON B-LYMPHOCYTES AND T-LYMPHOCYTES OF ATOPIC SUBJECTS, Clinical and experimental immunology, 112(2), 1998, pp. 276-280
The low-affinity IEE receptor (Fc epsilon RII/CD23) plays a role in Ig
E production. Cytokines participating in IgE synthesis also modulate C
D23 expression on lymphocytes, but whether this modulation is differen
t in atopic subjects remains unclear. We studied CD23 expression on B
and T lymphocytes in 10 asthmatic patients with Dermatophagoides ptero
nyssinus hypersensitivity and 10 healthy non-atopic subjects. Studies
were performed by flow cytometry, in phytohaemagglutinin (PHA) or IL-4
-stimulated mononuclear cell cultures, alone or in the presence of IFN
-gamma. Soluble CD23 (sCD23) released in the culture supernatants was
measured by enzyme-linked immunoassay. Both PHA and IL-4 induced the e
xpression of CD23 on lymphocytes of atopic and non-atopic subjects. Wh
ereas PHA increased both the percentage and mean fluorescence intensit
y of CD23(+) B and T cells, IL-4 alone did not increase the percentage
of CD23(+) T cells. The effects of IFN-gamma were different in both g
roups, since it was able to reduce the percentage of PHA-stimulated CD
23(+) T cells only in non-atopic individuals. In non-atopic subjects m
ore than atopic, levels of sCD23 were increased in the supernatants of
PHA and IL-4 cultures. These results show that the modulation of CD23
expression is different on B and T cells, and that IFN-gamma acts dif
ferently in atopic and non-atopic individuals.